Form 4: Quest Diagnostics Director Acquires Shares Through Dividend Reinvestment Plan

Robert B. Carter, a Director at Quest Diagnostics Inc., acquired 7 shares of common stock through a dividend reinvestment plan, increasing his beneficial ownership.

Summary

• Robert B. Carter, a Director of Quest Diagnostics Inc. (DGX), acquired 7 shares of common stock.
• The transaction occurred on July 21, 2025, at a price of $167.505 per share.
• The shares were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker.
• Carter's beneficial ownership of common stock following this transaction is 2,692 shares.
• The transaction was reported early on Form 4, although it was eligible for deferred reporting on Form 5 under Rule 16a-6.

Sentiment

Score: 6

Explanation: The sentiment is mildly positive. While the transaction amount is small and routine (dividend reinvestment), an insider's acquisition of shares, even through a DRIP, generally signals continued confidence in the company.

Positives

• A Director's acquisition of shares, even a small amount via dividend reinvestment, indicates continued confidence in the company's performance and future prospects.
• The use of a dividend reinvestment plan suggests a long-term investment strategy by the insider.

Future Outlook

The filing does not contain any explicit forward-looking statements or guidance regarding the company's future performance or strategic direction.

Industry Context

This filing reflects a routine insider transaction within the healthcare diagnostics industry. It does not provide broader insights into industry trends or competitive dynamics, but rather details an individual director's share ownership changes.

Stakeholder Impact

• Shareholders: The transaction indicates a director's continued investment in the company, which can be viewed as a positive signal of alignment with shareholder interests, though the impact is minimal due to the small transaction size.

Key Dates

Recommendation

This Form 4 filing details a small, routine acquisition of shares by a director through a dividend reinvestment plan. While it signals continued insider confidence, the transaction size is too small to warrant a change in investment recommendation. It is a standard disclosure and does not present new material information that would significantly alter the company's investment thesis.

Keywords

Quest Diagnostics, DGX, Form 4, Insider Trading, Director, Share Acquisition, Dividend Reinvestment Plan, Common Stock, Beneficial Ownership